MX2014012942A - Dialisato a base de polimero. - Google Patents
Dialisato a base de polimero.Info
- Publication number
- MX2014012942A MX2014012942A MX2014012942A MX2014012942A MX2014012942A MX 2014012942 A MX2014012942 A MX 2014012942A MX 2014012942 A MX2014012942 A MX 2014012942A MX 2014012942 A MX2014012942 A MX 2014012942A MX 2014012942 A MX2014012942 A MX 2014012942A
- Authority
- MX
- Mexico
- Prior art keywords
- polymer
- dialysate
- based dialysate
- polyglycerol
- kda
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title 1
- 229920000223 polyglycerol Polymers 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000009792 diffusion process Methods 0.000 abstract 1
- 239000002357 osmotic agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
- C08G65/22—Cyclic ethers having at least one atom other than carbon and hydrogen outside the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/0014—Special media to be introduced, removed or treated removed from the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0496—Urine
- A61M2202/0498—Urea
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2340/00—Filter material
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Polyethers (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
Abstract
Las incorporaciones descritas en el presente proporcionan un dialisato que comprende un poliglicerol. El poliglicerol puede tener un peso molecular entre alrededor de 0.15 kDa a alrededor de 60 kDa. También se proporciona en el presente el uso del dialisato como un agente de difusión y como un agente osmótico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261637716P | 2012-04-24 | 2012-04-24 | |
PCT/CA2013/000382 WO2013159188A1 (en) | 2012-04-24 | 2013-04-18 | Polymer-based dialysate |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2014012942A true MX2014012942A (es) | 2015-02-10 |
Family
ID=49482059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014012942A MX2014012942A (es) | 2012-04-24 | 2013-04-18 | Dialisato a base de polimero. |
Country Status (15)
Country | Link |
---|---|
US (1) | US9919004B2 (es) |
EP (1) | EP2841078A4 (es) |
JP (1) | JP6240665B2 (es) |
KR (1) | KR20150013161A (es) |
CN (1) | CN104640550A (es) |
AU (1) | AU2013252433B2 (es) |
BR (1) | BR112014026616A2 (es) |
CA (1) | CA2871277A1 (es) |
CL (1) | CL2014002891A1 (es) |
CO (1) | CO7190239A2 (es) |
HK (1) | HK1203388A1 (es) |
MX (1) | MX2014012942A (es) |
MY (1) | MY170307A (es) |
PE (1) | PE20150288A1 (es) |
WO (1) | WO2013159188A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006130978A1 (en) | 2005-06-06 | 2006-12-14 | The University Of British Columbia | Polymer-based serum albumin substitute |
CN102906157B (zh) | 2010-03-01 | 2016-08-24 | 不列颠哥伦比亚大学 | 衍生的超支化聚丙三醇 |
CA2936650C (en) * | 2013-11-21 | 2022-06-21 | The University Of British Columbia | Polymer based transplant preservation solution |
CA2949868C (en) | 2014-05-29 | 2022-07-26 | The University Of British Columbia | Antithrombotic compounds, methods and uses thereof |
EP3120842A1 (en) * | 2015-07-20 | 2017-01-25 | Opterion Health AG | Peritoneal therapeutic fluid |
JP6721880B2 (ja) * | 2016-03-25 | 2020-07-15 | 国立大学法人神戸大学 | 正浸透膜を使用して膜分離する方法 |
US10874790B2 (en) | 2016-08-10 | 2020-12-29 | Medtronic, Inc. | Peritoneal dialysis intracycle osmotic agent adjustment |
GR1009311B (el) * | 2017-01-26 | 2018-06-19 | Βερμα Ντραγκς - Verma Drugs Abee | Οξινο κιτρικο διαλυμα αιμοκαθαρσης με l-καρνιτινη |
EP3381484A1 (en) * | 2017-03-31 | 2018-10-03 | Opterion Health AG | Carbohydrate composition for dialysis |
WO2019210414A1 (en) * | 2018-05-02 | 2019-11-07 | Arc Medical Devices Inc. | Fucan-based compounds and complexes |
US11806457B2 (en) * | 2018-11-16 | 2023-11-07 | Mozarc Medical Us Llc | Peritoneal dialysis adequacy meaurements |
US11806456B2 (en) | 2018-12-10 | 2023-11-07 | Mozarc Medical Us Llc | Precision peritoneal dialysis therapy based on dialysis adequacy measurements |
US11965763B2 (en) | 2021-11-12 | 2024-04-23 | Mozarc Medical Us Llc | Determining fluid flow across rotary pump |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3461210A (en) * | 1967-07-20 | 1969-08-12 | Unimed Inc | Reduction of intraocular pressure |
JPS61247466A (ja) * | 1985-04-25 | 1986-11-04 | テルモ株式会社 | 腹膜透析用透析液 |
US20030202958A1 (en) * | 1999-10-15 | 2003-10-30 | Strickland Alan D. | Dialysis solution including polyglycol osmotic agent |
CA2382864A1 (en) * | 1999-10-15 | 2001-04-26 | The Dow Chemical Company | Dialysis solution including polyglycol osmotic agent |
US6949335B2 (en) * | 1999-11-30 | 2005-09-27 | 21St Century Medicine, Inc. | Polyglycerol and lactose compositions for the protection of living systems from states of reduced metabolism |
WO2006130978A1 (en) * | 2005-06-06 | 2006-12-14 | The University Of British Columbia | Polymer-based serum albumin substitute |
DE102006036326A1 (de) * | 2006-08-03 | 2008-02-07 | Charité - Universitätsmedizin Berlin | Dendritische Polyglycerolsulfate und -sulfonate und deren Verwendung bei entzündlichen Erkrankungen |
WO2008074154A1 (en) | 2006-12-18 | 2008-06-26 | The University Of British Columbia | Polymers comprising zwitterionic endgroups |
CA2742345A1 (en) | 2007-11-02 | 2009-05-07 | The University Of British Columbia | Hyperbranched polyglycerol for improving heart function |
CN102906157B (zh) | 2010-03-01 | 2016-08-24 | 不列颠哥伦比亚大学 | 衍生的超支化聚丙三醇 |
WO2012162789A1 (en) | 2011-06-01 | 2012-12-06 | University Of British Columbia | Polymers for reversing heparin-based anticoagulation |
-
2013
- 2013-04-18 PE PE2014001790A patent/PE20150288A1/es not_active Application Discontinuation
- 2013-04-18 CA CA2871277A patent/CA2871277A1/en not_active Abandoned
- 2013-04-18 BR BR112014026616A patent/BR112014026616A2/pt not_active IP Right Cessation
- 2013-04-18 EP EP13780839.0A patent/EP2841078A4/en not_active Withdrawn
- 2013-04-18 JP JP2015507307A patent/JP6240665B2/ja not_active Expired - Fee Related
- 2013-04-18 WO PCT/CA2013/000382 patent/WO2013159188A1/en active Application Filing
- 2013-04-18 AU AU2013252433A patent/AU2013252433B2/en not_active Ceased
- 2013-04-18 CN CN201380032067.7A patent/CN104640550A/zh active Pending
- 2013-04-18 MX MX2014012942A patent/MX2014012942A/es unknown
- 2013-04-18 MY MYPI2014003013A patent/MY170307A/en unknown
- 2013-04-18 US US14/396,603 patent/US9919004B2/en not_active Expired - Fee Related
- 2013-04-18 KR KR1020147031465A patent/KR20150013161A/ko not_active Application Discontinuation
-
2014
- 2014-10-24 CL CL2014002891A patent/CL2014002891A1/es unknown
- 2014-11-12 CO CO14250262A patent/CO7190239A2/es unknown
-
2015
- 2015-04-24 HK HK15104009.4A patent/HK1203388A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2871277A1 (en) | 2013-10-31 |
PE20150288A1 (es) | 2015-02-22 |
CO7190239A2 (es) | 2015-02-19 |
US9919004B2 (en) | 2018-03-20 |
AU2013252433A1 (en) | 2014-11-20 |
JP6240665B2 (ja) | 2017-11-29 |
WO2013159188A1 (en) | 2013-10-31 |
HK1203388A1 (en) | 2015-10-30 |
JP2015515481A (ja) | 2015-05-28 |
KR20150013161A (ko) | 2015-02-04 |
EP2841078A1 (en) | 2015-03-04 |
BR112014026616A2 (pt) | 2017-06-27 |
EP2841078A4 (en) | 2015-11-04 |
US20150141512A1 (en) | 2015-05-21 |
MY170307A (en) | 2019-07-17 |
CN104640550A (zh) | 2015-05-20 |
AU2013252433B2 (en) | 2017-12-14 |
CL2014002891A1 (es) | 2015-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014012942A (es) | Dialisato a base de polimero. | |
MX366557B (es) | Protectores de dispositivo medico portatil. | |
SI2739615T1 (sl) | Fenil-3-aza-biciklo(3.1.0)heks-3-il-metanoni in njihova uporaba kot zdravilo | |
AU344288S (en) | Game controller | |
MX346891B (es) | Formulaciones en espuma que incluyen poliesteres de silicona. | |
MX2015004937A (es) | Formulaciones de electrolito para un calentador portatil activado por oxigeno. | |
BR112012033231A2 (pt) | peças revestidas e seu uso | |
AU342848S (en) | Multifaceted gemstone design | |
AU342849S (en) | Multifaceted gemstone design | |
AU342851S (en) | Multifaceted gemstone design | |
IL236776A0 (en) | Use of antithrombin in extracorporeal membrane oxidation | |
MX355932B (es) | Formulaciones en espuma que incluyen poliuretanos basados en silicona. | |
AR088016A1 (es) | Articulo absorbente | |
EP3064517A4 (en) | Fluorine-containing polymer, and surface modifier containing same as active ingredient | |
MX344189B (es) | Formulaciones de mazindol. | |
HK1198632A1 (en) | Compositions comprising cimetidine and n,o-carboxymethyl chitosan for the prevention and therapy of pathologies of the skin and the mucous membranes and in the odontostomatological field no- | |
AU335861S (en) | Trimming device with connecting member for razor attachment | |
WO2013138338A3 (en) | Methods for treating tissue damage associated with ischemia with apoliporotein d | |
AU335899S (en) | Hand guard | |
AR098243A1 (es) | Artículo absorbente | |
CA142814S (en) | Medical patch | |
Long | Two Powers, One Ability-Understanding and Imagination in Kant | |
MY172499A (en) | An antimicrobial film composite | |
UA52379U (ru) | Применение ЛИПИНА в качестве средства фригопротекторного действия | |
UA52378U (ru) | Применение ЛИПОФЛАВОНА в качестве средства фригопротекторного действия |